Navigation Links
ViroPharma Provides 2008 Outlook
Date:1/9/2008

2008 Focus on Pipeline Advancement; CAMVIA Momentum Building Toward 2009

NDA

EXTON, Pa., Jan. 9 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced Michel de Rosen, ViroPharma's president and chief executive officer, will provide an overview of the company's business and present a financial update during the 26th Annual JPMorgan Healthcare Conference. As previously announced, this presentation will be webcast live at 2:00 P.M. Pacific Time on Wednesday, January 9, 2008 and may be accessed via the company's website at http://www.viropharma.com. The company expects to release full-year 2007 financial results and further discuss 2008 guidance later in the first quarter of 2008.

"We are in the midst of a period of great momentum and promise," said Michel de Rosen, ViroPharma's Chief Executive Officer. "For example, we expect to build on the great clinical progress we are currently experiencing in our ongoing Phase 3 program with CAMVIA(TM)(maribavir) as we move toward our goal of a 2009 NDA filing. We also continue to work diligently in our pre-launch activities for CAMVIA to refine our plans for medical education, marketing and communications, and ensure a successful launch. We also are extremely excited about moving our unique non-toxigenic C. difficile (NTCD) program into humans during the year; we believe that this novel approach could one day be the therapy of choice for recurrent C. difficile infection (CDI), which remains a significant medical need in CDI patients. As a reminder, we along with Wyeth continue to work diligently to elucidate the path forward for our HCV program which we hope will reinvigora
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. ViroPharma to Present at Two Upcoming Healthcare Conferences
2. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
3. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
4. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
5. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
6. Vasogen Provides an Update on ACCLAIM-II Preparations
7. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
8. NanoLogix Inc. Sets Date for Annual Shareholder Meeting and Provides Shareholder Update
9. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
10. New Scrip Report Provides Strategic Insight on the Burgeoning Biosimilars Market
11. Pressure BioSciences, Inc. Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 AudioNotch is ... new therapy for the treatment of tinnitus. Patients listen ... frequency, and over a period of weeks to months, their ... Therapy in two forms: Notched Music and Notched White Noise. ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 ... Almshouse Road, Warrington, Pa. , Details: The Hepatitis ... finding a cure for hepatitis B and improving the quality ... Crystal Ball on Friday, April 11 at Warrington Country Club ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Histogen, Inc., ... products of cells grown under simulated embryonic conditions, today ... agreement with Suneva Medical, Inc. for physician-dispensed aesthetic products ... , This agreement is an amendment to the ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... Jordan , Caliper Life Sciences, ... Introduction , The ... Liquid Handler (ALH). This device is designed to permit individually and independently ... microplates for purposes of liquid transfer (tertiary dispensing). It can be configured ...
... Rudy Willebrords 1 and Bart Moyson ... 1 Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica ... 2 Caliper Life Sciences Benelux NV, Teralfene, Belgium ... The purpose of this paper is to report ...
... Lynn Jordan , ... Introduction , ... across multi-well plates and into individual columns (secondary dispensing) is of ... precision that can be achieved during a series of dispenses. Therefore, ...
Cached Biology Technology:Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option 2Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option 3Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option 4Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option 596 Well Pipetting Precision Testing Using the Sciclone ALH with a 384 Fixed-Cannula Array 296 Well Pipetting Precision Testing Using the Sciclone ALH with a 384 Fixed-Cannula Array 3Sciclone ALH Bulk Dispense Precision Testing 2
(Date:4/24/2014)... brain infection caused by fungus could now be treated in ... University of Liverpool scientists. , Cryptococcus a ... relatively neglected in medical research. They are found in ... East Asia and mainly affect people with weakened immune systems. ... The University research team has tested the effects of the ...
(Date:4/24/2014)... with new insights into the make-up of tropical forests, ... Basin have revealed unprecedented detail of the size, age ... satellite maps with hundreds of field plots. , ... the amount of carbon each tree can store. This ... which trees are given a cash value according to ...
(Date:4/24/2014)... droplet of clear liquid can bend light, acting as ... have developed a new process to create inexpensive high ... apiece. , Because they,re so inexpensive, the lenses ... tools to detect diseases in the field, scientific research ... education in classrooms. , "What I,m really excited ...
Breaking Biology News(10 mins):Treatment for deadly yeast disease reduced to 3 days 2Amazon rainforest survey could improve carbon offset schemes 2Bake your own droplet lens 2Bake your own droplet lens 3
... kills more people than breast, colorectal, pancreatic, and prostate ... the leading cause of mortality in intensive care units. ... fatal disease. Thanks to a generous grant of $138,238.65 ... Research Institute,s Dr. Michael Sharpe is exploring a new ...
... publication of new names in algae, fungi, and plants accepted ... paper that is being published simultaneously or will be published ... paper, co-authored by Sandra Knapp (London), John McNeill (Edinburgh) and ... articles to the Code and some ideas for ...
... No, this isn,t Jurassic Park. Researchers at the Johns Hopkins ... hunter in College Park, Md., have described the fossil of ... discovered, and a founder of a new genus and species ... Cretaceous Era. Nodosaurs have been found in diverse locations worldwide, ...
Cached Biology News:Could an apple a day keep sepsis away? 2Revolutionary changes to the Botanical Code published in 16 journals and 5 languages 2Newborn dinosaur discovered in Maryland 2
... The Multiple Species Tissue Array (MSTA) slides ... different cells and tissues from multiple species. ... on each MSTA slide which can then be ... staining, immunohistochemistry, or in situ hybridization. ...
... Medium (TSB), USP is a highly nutritious ... laboratory use. Due to the inclusion of ... will support growth of many fastidious organisms ... Product conforms to United States Pharmacopeia standards ...
... The Gene Pulser Xcell ... V, 50-60 Hz, is used ... This system includes the main ... (25-3,275 microfarad range) or square-wave ...
AVOID FREEZE/THAW CYCLES. Recognizes the ~5 kDa thymosin beta4 protein....
Biology Products: